Holen Sie sich die Stockscreener-App
7.27
1.54%
0.11
Handel nachbörslich:
7.24
-0.03
-0.41%
Schlusskurs vom Vortag:
$7.16
Offen:
$7.3
24-Stunden-Volumen:
894.44K
Relative Volume:
0.75
Marktkapitalisierung:
$694.34M
Einnahmen:
$1,000.00K
Nettoeinkommen (Verlust:
$-48.81M
KGV:
-9.3964
EPS:
-0.7737
Netto-Cashflow:
$-39.95M
1W Leistung:
+2.83%
1M Leistung:
+0.14%
6M Leistung:
+92.84%
1J Leistung:
+830.98%
1-Tages-Spanne:
$7.215
$7.42
1-Wochen-Bereich:
$6.90
$7.9399
52-Wochen-Spanne:
$0.712
$8.33
Shattuck Labs Inc Stock (STTK) Company Profile
Firmenname
Shattuck Labs Inc
Sektor
Branche
Telefon
512-900-4690
Adresse
500 W. 5TH STREET, AUSTIN
Compare STTK vs VRTX, REGN, ARGX, RVMD, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STTK
Shattuck Labs Inc
|
7.27 | 672.38M | 1,000.00K | -48.81M | -39.95M | -0.7737 |
VRTX
Vertex Pharmaceuticals Inc
|
496.07 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
784.36 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
865.04 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
205.15 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
348.27 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2026-03-06 | Fortgesetzt | Needham | Buy |
| 2026-01-28 | Eingeleitet | Piper Sandler | Overweight |
| 2025-12-01 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-09-08 | Eingeleitet | Wedbush | Outperform |
| 2025-03-17 | Eingeleitet | Leerink Partners | Outperform |
| 2024-10-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-10-02 | Herabstufung | Needham | Buy → Hold |
| 2024-10-01 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-08-31 | Eingeleitet | BTIG Research | Buy |
| 2022-06-01 | Eingeleitet | Citigroup | Buy |
| 2022-05-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-14 | Eingeleitet | Berenberg | Buy |
| 2021-01-11 | Eingeleitet | Evercore ISI | Outperform |
| 2020-11-03 | Eingeleitet | Citigroup | Buy |
| 2020-11-03 | Eingeleitet | Cowen | Outperform |
| 2020-11-03 | Eingeleitet | Needham | Buy |
Alle ansehen
Shattuck Labs Inc Aktie (STTK) Neueste Nachrichten
STTK|Shattuck Labs Inc|Price:7.430| - TradingKey
Shattuck Labs Inc (STTK) Institutional Confidence - TradingKey
Shattuck Labs Inc (STTK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
STTK|Shattuck Labs Inc|Price:7.430|Chg%:+0.340 - TradingKey
Shattuck Labs Inc (STTK) Balance Sheet - TradingKey
Shattuck Labs Inc (STTK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Shattuck Labs Inc (STTK) Cash Flow - TradingKey
STTK Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive SentimentFull Year Guidance - dars.gov.et
Why Shattuck Labs Stock Flew Nearly 5% Higher on Friday - The Globe and Mail
Why Shattuck Labs Stock Flew Nearly 5% Higher on Friday - The Motley Fool
STTK Initiated Coverage by JP Morgan -- Rating Set at Overweight - GuruFocus
This Shattuck Labs Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday - Benzinga
JPMorgan Initiates Shattuck Labs at Overweight With $10 Price Target - marketscreener.com
JPMorgan reiterates Shattuck Labs stock rating on DR3 program By Investing.com - Investing.com Canada
JPMorgan reiterates Shattuck Labs stock rating on DR3 program - Investing.com
Shattuck Labs Inc (STTK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Redmile Group, LLC Increases Stake in Shattuck Labs Inc - GuruFocus
Shattuck Labs Inc. (STTK) Drops Sharply as Biotech Sector Faces HeadwindsIron Condor Alert - dars.gov.et
STTK Initiated Coverage by Leerink Partners -- Rating Set to Out - GuruFocus
Form 13D/A Shattuck Labs For: 20 July By Investing.com - Investing.com Nigeria
STTK stock trades steady as Shattuck Labs highlights cash position and clinical progress - Ad-hoc-news.de
Form 13D/A Shattuck Labs For: 17 July By Investing.com - Investing.com Nigeria
Redmile updates 9.9% Shattuck Labs (STTK) stake after July trades - Stock Titan
Shattuck Labs, Inc. (STTK) Discusses Phase I Results for DR3 Blocking Antibody SL-325 and Pipeline UpdateSlideshow (NASDAQ:STTK) 2026-07-08 - Seeking Alpha
Shattuck Labs CTO Abhinav Shukla sells $2,874 in company stock By Investing.com - Investing.com Nigeria
Shattuck Labs CTO Abhinav Shukla sells $2,874 in company stock - Investing.com
Form 4 Shattuck Labs Inc For: 7 July By Investing.com - Investing.com Nigeria
Shattuck Labs (STTK) CTO exercises options and makes small 10b5-1 sale - Stock Titan
Shattuck Labs outlines its oncology platform as investors assess long-term prospects - ad-hoc-news.de
STTKShattuck Labs Inc Options - Finviz
STTK Q1 2026 Earnings: Narrower-Than-Expected Net Loss Boosts Investor SentimentRevenue Warning Signal - dars.gov.et
Shattuck Labs focuses on immunotherapy pipeline as investors watch clinical milestones - Ad-hoc-news.de
Insider Sell: Arundathy Pandite Sells 30,000 Shares of Shattuck Labs Inc (STTK) - GuruFocus
Shattuck Labs cmo Pandite sells $210,300 in company stock - Investing.com UK
Abhinav Shukla, Shattuck Labs CTO, sells $166,131 in stock By Investing.com - Investing.com South Africa
Form 4 Shattuck Labs Inc For: 2 July By Investing.com - Investing.com Canada
Shattuck Labs cmo Pandite sells $210,300 in company stock By Investing.com - Investing.com Australia
Abhinav Shukla, Shattuck Labs CTO, sells $166,131 in stock - Investing.com
Shattuck Labs (NASDAQ: STTK) CTO option exercises and 23,465-share sale disclosed - Stock Titan
Shattuck Labs (STTK) CMO sells 30,000 shares under 10b5-1 plan - Stock Titan
Form 144 Shattuck Labs For: 2 July By Investing.com - Investing.com Nigeria
410-share sale reported by STTK insider (NASDAQ: STTK) via option exercise - Stock Titan
Form 144 Shattuck Labs For: 1 July By Investing.com - Investing.com South Africa
Abhinav A. Shukla (STTK) files to sell 100 common shares via Form 144 - Stock Titan
Finanzdaten der Shattuck Labs Inc-Aktie (STTK)
Umsatz
Nettogewinn
Free Cashflow
ENV
Shattuck Labs Inc-Aktie (STTK) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Shukla Abhinav A. | Chief Technical Officer |
Jul 02 '26 |
Option Exercise |
3.57 |
410 |
1,464 |
86,790 |
| Shukla Abhinav A. | Chief Technical Officer |
Jul 02 '26 |
Sale |
7.01 |
410 |
2,874 |
86,380 |
| Shukla Abhinav A. | Chief Technical Officer |
Jun 30 '26 |
Option Exercise |
3.57 |
23,365 |
83,413 |
109,745 |
| Shukla Abhinav A. | Chief Technical Officer |
Jul 01 '26 |
Option Exercise |
3.57 |
100 |
357 |
86,480 |
| Shukla Abhinav A. | Chief Technical Officer |
Jun 30 '26 |
Sale |
7.08 |
23,365 |
165,424 |
86,380 |
| Shukla Abhinav A. | Chief Technical Officer |
Jul 01 '26 |
Sale |
7.07 |
100 |
707 |
86,380 |
| Pandite Arundathy N. | Chief Medical Officer |
Jun 30 '26 |
Sale |
7.01 |
30,000 |
210,300 |
136,219 |
1.84%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):